Melannie Alexander1,2, Jie Lin1,2,3,4, Craig D Shriver1,3, Katherine A McGlynn5, Kangmin Zhu1,2,3,4. 1. Department of Surgery, John P. Murtha Cancer Center Research Program, Walter Reed National Military Medical Center, Uniformed Service University of the Health Sciences, Bethesda, MD, USA. 2. Henry M. Jackson Foundation for the Advancement of Military Medicine, Bethesda, MD, USA. 3. Departmentof Surgery, Walter Reed National Military Medical Center, Uniformed Service University of the Health Sciences, Bethesda, MD, USA. 4. Departmentof Preventive Medicine and Biostatistics, Uniformed Services University of the Health Sciences, Bethesda, MD, USA. 5. Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA.
Abstract
AIM: Larger tumour size and lymph node involvement traditionally predict poorer survival in colon cancer patients. However, it has been recently suggested that very small tumours (<5 mm) may be a predictor of poor prognosis in colon cancer patients when lymph nodes are involved. This study investigated whether node-positive colon cancer patients with small tumours had worse survival compared to those with larger tumours in the Department of Defense's (DoD) Military Health System (MHS), a universal health care system. METHODS: Surgically treated colon cancer patients were identified from the DoD's Automated Central Tumour Registry (ACTUR). These patients were diagnosed with Stage I-III colon cancer between 1989 and 2010, had one or more lymph nodes examined, did not receive pre-operative radiotherapy and were followed through 2013 to determine vital status. Multivariable Cox models were used to examine survival differences according to tumour size, and data were stratified by lymph node status and age. RESULTS: There were no differences in overall survival according to tumour size in the study population. These findings remained similar in analyses stratified by lymph node status and age. CONCLUSION: In a universal healthcare system, small tumour size is not associated with worse prognosis in node-positive colon cancer patients.
AIM: Larger tumour size and lymph node involvement traditionally predict poorer survival in colon cancer patients. However, it has been recently suggested that very small tumours (<5 mm) may be a predictor of poor prognosis in colon cancer patients when lymph nodes are involved. This study investigated whether node-positive colon cancer patients with small tumours had worse survival compared to those with larger tumours in the Department of Defense's (DoD) Military Health System (MHS), a universal health care system. METHODS: Surgically treated colon cancer patients were identified from the DoD's Automated Central Tumour Registry (ACTUR). These patients were diagnosed with Stage I-III colon cancer between 1989 and 2010, had one or more lymph nodes examined, did not receive pre-operative radiotherapy and were followed through 2013 to determine vital status. Multivariable Cox models were used to examine survival differences according to tumour size, and data were stratified by lymph node status and age. RESULTS: There were no differences in overall survival according to tumour size in the study population. These findings remained similar in analyses stratified by lymph node status and age. CONCLUSION: In a universal healthcare system, small tumour size is not associated with worse prognosis in node-positive colon cancer patients.
Authors: H Nelson; N Petrelli; A Carlin; J Couture; J Fleshman; J Guillem; B Miedema; D Ota; D Sargent Journal: J Natl Cancer Inst Date: 2001-04-18 Impact factor: 13.506
Authors: Hans-Joachim Schmoll; Chris Twelves; Weijing Sun; Michael J O'Connell; Thomas Cartwright; Edward McKenna; Muhammad Saif; Steve Lee; Greg Yothers; Daniel Haller Journal: Lancet Oncol Date: 2014-11-12 Impact factor: 41.316
Authors: Jai Min Ryu; Hyouk Jin Lee; Tae In Yoon; Eun Sook Lee; Soo Jung Lee; Jin Hyang Jung; Byung Joo Chae; Seok Jin Nam; Jeong Eon Lee; Se Kyung Lee; Soo Youn Bae; Jonghan Yu; Seok Won Kim Journal: Breast Cancer Res Treat Date: 2016-09-02 Impact factor: 4.872
Authors: Vinayak Muralidhar; Ryan D Nipp; David P Ryan; Theodore S Hong; Paul L Nguyen; Jennifer Y Wo Journal: Dis Colon Rectum Date: 2016-03 Impact factor: 4.585
Authors: Jon D Vogel; Cagla Eskicioglu; Martin R Weiser; Daniel L Feingold; Scott R Steele Journal: Dis Colon Rectum Date: 2017-10 Impact factor: 4.585
Authors: Vinayak Muralidhar; Ryan D Nipp; Harvey J Mamon; Rinaa S Punglia; Theodore S Hong; Cristina Ferrone; Carlos Fernandez-Del Castillo; Aparna Parikh; Paul L Nguyen; Jennifer Y Wo Journal: Ann Surg Oncol Date: 2018-10-08 Impact factor: 5.344
Authors: Peter Kornprat; Marion J Pollheimer; Richard A Lindtner; Andrea Schlemmer; Peter Rehak; Cord Langner Journal: Am J Clin Oncol Date: 2011-02 Impact factor: 2.339
Authors: Olatunji B Alese; Wei Zhou; Renjian Jiang; Katerina Zakka; Zhonglu Huang; Chimuanya Okoli; Walid L Shaib; Mehmet Akce; Maria Diab; Christina Wu; Bassel F El-Rayes Journal: Front Oncol Date: 2021-12-09 Impact factor: 6.244